Trials / Completed
CompletedNCT05426902
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to pilot test SLE@Duke, a set of tools to implement the Type 1 \& 2 SLE Model in a clinical setting, as well as to gain an in-depth understanding of providers experiences using the intervention during clinic visits with patients with systemic lupus erythematosus. This record represents Aim 3 of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SLE@Duke | SLE@Duke is a set of tools to implement the Type 1 \& 2 SLE Model in a clinical setting. The model includes an Electronic Medical Record (EMR) note template, patient-reported outcome measure, and training on how to discuss Type 1 \& 2 SLE. |
Timeline
- Start date
- 2022-01-03
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2022-06-22
- Last updated
- 2023-09-14
- Results posted
- 2023-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05426902. Inclusion in this directory is not an endorsement.